Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | GRM5 | P41594 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | PTPRA | P18433 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | APAF1 | O14727 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7571404 | 0.84 | PTGER1 (0.48) | CYP1A2PTPRAMAPTKMT2AKDM4E | |
| SCHEMBL18710702 | 0.80 | NPC1 (0.47) | GRM5CYP1A2MAPTNPC1RAB9A | |
| SCHEMBL27285205 | 0.74 | AAK1 (0.49) | PPARGPPARDPPARAGRM5CYP1A2 | |
| SCHEMBL21056985 | 0.72 | TSHR (0.56) | PPARGPPARDPPARANPC1RAB9A | |
| SCHEMBL21056989 | 0.72 | TSHR (0.56) | PPARGPPARDPPARANPC1RAB9A | |
| SCHEMBL30640053 | 0.72 | TSHR (0.56) | PPARGPPARDPPARANPC1RAB9A | |
| SCHEMBL28456431 | 0.72 | NPC1 (0.43) | GRM5CYP1A2MAPTNPC1RAB9A | |
| SCHEMBL13002972 | 0.71 | KMO (0.42) | PPARACYP1A2MAPTRAB9AALDH1A1 | |
| SCHEMBL12713189 | 0.71 | PPARA (0.43) | PPARGPPARACYP1A2MAPTRAB9A | |
| SCHEMBL17661920 | 0.71 | NPC1 (0.50) | GRM5CYP1A2MAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218021-A1 | CYCLIN INHIBITORS | CIRCLE PHARMA, INC. | 2024-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240218021-A1 | CYCLIN INHIBITORS | CCNI, CCNC, CDK2 | PPARG 1553/4885PPARD 2693/4885PPARA 2803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.